FKBP1A has also been shown to inhibit TGF-beta type 1 receptor [49] and it was found overexpressed in childhood astrocytomas, which presented as the EGFR/FKBP12/HIF-2alpha pathway [50]. This evidence concerns the gene EGFR and astrocytoma (excluding glioblastoma).